Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes Aging & Longevity

Global Baby Bust: Why Falling Birthrates Are a Red Flag for Investors

by Team Lumida
May 17, 2024
in Aging & Longevity, Health and Longevity, Lifestyle, Macro, News, Themes
Reading Time: 3 mins read
A A
0
small kid standing on planked footpath

Photo by Tatiana Syrikova on Pexels.com

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

  1. Global fertility rates are dropping below replacement levels.
  2. Economic growth, labor forces, and global power dynamics face serious risks.
  3. Governments struggle with ineffective pronatalist policies to reverse trends.

What Happened?

Fertility rates worldwide are plummeting, with many countries now reporting birthrates below the replacement level needed to maintain population size. In high-income countries, fertility has been below replacement since the 1970s, but developing nations are also experiencing significant declines.

India, which recently surpassed China as the most populous country, now has a fertility rate below replacement. Estimates suggest global fertility fell to between 2.1 and 2.2 last year, marking a potential historic low. Governments worldwide have launched various initiatives to combat this trend, but these efforts have yet to make a significant impact.

Why It Matters?

The economic, social, and geopolitical consequences are profound. A shrinking workforce can slow economic growth, strain pension systems, and reduce a country’s global influence. For investors, this demographic shift signals potential challenges and opportunities.

Companies in industries like childcare, education, and healthcare may face declining demand, while those involved in elder care and automation could see growth. Understanding these trends is crucial for adjusting investment strategies and anticipating market shifts.

What’s Next?

Governments will likely continue to implement and refine pronatalist policies, though their effectiveness remains uncertain. Countries may also seek to mitigate the economic impact through increased immigration, despite potential political resistance. Investors should monitor how these demographic changes influence market dynamics, particularly in sectors directly affected by population shifts.

Innovations and policies aimed at boosting productivity and supporting aging populations will play a critical role in shaping the future economic landscape.

Previous Post

Commercial Property Crisis: High Rates Push Owners to Tough Decisions

Next Post

Why Investors Are Going Crazy for Copper: The $43 Billion Battle

Recommended For You

S&P 500 Snaps Four-Day Slide as Oil Retreats, With Markets Treating a September Fed Hike as Nearly Certain

by Team Lumida
4 hours ago
Will September’s Fed Rate Cuts Surprise Investors? Here’s What Deutsche Bank Predicts

Stocks rose Friday as Brent slipped from a four-month high, but August core CPI came in warm enough that money markets now see a Fed hike next week...

Read more

Ipsen Weighs Return to US Manufacturing as Tariff Pressure Pulls European Drugmakers Onshore

by Team Lumida
5 hours ago
Ipsen Weighs Return to US Manufacturing as Tariff Pressure Pulls European Drugmakers Onshore

French drugmaker Ipsen is considering a US production site for Dysport or a next-generation successor, joining AstraZeneca, Roche, UCB and CSL in onshoring plans.

Read more

Ellison to Sell Up to 50 Million Oracle Shares Worth $7.5 Billion as Margins Compress on the OpenAI Build-Out

by Team Lumida
5 hours ago
Oracle’s Q4 earnings missed expectations but stock jumped ~11% after new cloud deals

Oracle chair Larry Ellison will sell as many as 50 million shares through October under a plan set up in June, days after the company flagged further margin...

Read more

Apple Holds iPhone Price Rises to $100 as Memory Costs Bite, Betting Margin for Volume in Ternus’s First Test

by Team Lumida
22 hours ago
Apple Holds iPhone Price Rises to $100 as Memory Costs Bite, Betting Margin for Volume in Ternus’s First Test

New Apple CEO John Ternus priced the foldable iPhone Duo just under $2,000 and capped broader increases at $100, absorbing memory cost inflation to protect volume.

Read more

Enflame Jumps 206% on Shanghai Debut as Retail Orders Hit 6,000x Book, Completing China’s AI Chip IPO Wave

by Team Lumida
22 hours ago
nvidia graphics processing unit

Tencent-backed Enflame soared 206% in its Shanghai debut, the last of China's four little dragons of AI chipmaking to list after MetaX, Moore Threads and Biren.

Read more

Anthropic and OpenAI Researchers Sound Alarm on Recursive Self-Improvement as Alignment Lead Puts Extinction Risk Above 10%

by Team Lumida
22 hours ago
brown wooden hallway with gray metal doors

Researchers at both leading AI labs warned this week that models are accelerating their own development faster than expected, reviving loss-of-control concerns.

Read more

BMO and Sun Life Commit C$75 Billion to Canada’s Infrastructure Build, Days Before Carney’s Toronto Investor Summit

by Team Lumida
23 hours ago
BMO and Sun Life Commit C$75 Billion to Canada’s Infrastructure Build, Days Before Carney’s Toronto Investor Summit

BMO pledged up to C$70 billion over a decade and Sun Life C$5 billion for Canadian infrastructure, ahead of Mark Carney's investor summit in Toronto.

Read more

10-Year Treasury Yield Hits 4.94%, Closest to 5% Since 2023 as Traders Price 70% Odds of a September Fed Hike

by Team Lumida
23 hours ago
Saudi Arabia Leads $321B EM Bond Spree: What Investors Need to Know

The 10-year Treasury yield climbed to 4.94% ahead of August CPI, with traders pricing roughly 70% odds of a Fed rate hike on Sept. 16.

Read more

Genius Act’s Stablecoin Framework Could Reinforce Dollar But Carries Systemic Risks, Economists Warn

by Team Lumida
24 hours ago
SEC Approval Boosts Crypto Funds: $1.2B Invested in a Week

Genius Act legalizes dollar-backed stablecoins to boost Treasury demand and dollar dominance, but economists warn of limited interest-rate benefits and systemic destabilization risks.

Read more

Moonshot AI Targets $2B Annualized Revenue by Year-End, Riding Kimi K3 Breakout Success

by Team Lumida
1 day ago
AI Stock-Analytics Chatbot BridgeWise Expands to Dubai as Regional Hub

Moonshot AI targets $2 billion annualized revenue by year-end, riding Kimi K3 success to a $50 billion valuation ahead of Hong Kong IPO.

Read more
Next Post
brown and white rope on brown wooden surface

Why Investors Are Going Crazy for Copper: The $43 Billion Battle

man during magnetic resonance imaging

The Truth About Full-Body MRIs: A $2,500 Investment in Your Health?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

FDA Reverses Rejection of Regenxbio Gene Therapy for Fatal Rare Disease

FDA Reverses Rejection of Regenxbio Gene Therapy for Fatal Rare Disease

June 22, 2026
woman in gray hoodie sweater jogging

This 55-Year-Old’s Simple Routine Beats Millionaires at Anti-Aging

May 17, 2024
The Procter & Gamble Company (PG) Q2 2025 Earnings

The Procter & Gamble Company (PG) Q2 2025 Earnings

January 23, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018